Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Weiten, Richard; Rieger, Constantin; Heidenreich, Julian; Tolkach, Yuri; Stehle, Thomas; Schmid, Florian; Schmidt, Teresa; Glas, Martin; Blau, Tobias; Keyvani, Kathy; Büttner, Thomas; Grünwald, Viktor; Hölzel, Michael; Heidenreich, Axel; Eckstein, Markus; Klümper, Niklas
    NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma
    In: European Urology Open Science, Jg. 86, 2026, S. 42 – 46
  • Holtkamp, Mathias; Parmar, Vicky; Hosch, René; Salhöfer, Luca; Styczen, Hanna; Li, Yan; Opitz, Marcel; Glas, Martin; Guberina, Nika; Wrede, Karsten; Deuschl, Cornelius; Forsting, Michael; Nensa, Felix; Umutlu, Lale; Haubold, Johannes
    AI-guided virtual biopsy : Automated differentiation of cerebral gliomas from other benign and malignant MRI findings using deep learning
    In: Neuro-Oncology Advances, Jg. 7, 2025, Nr. 1, vdae225
  • Oster, Christoph; Matyar, Aylin; Schmidt, Teresa; Hummel, Thomas; Hattingen, Elke; Jokisch, Martha; Jokisch, Daniel; Grieger, Jana; Cappello, Giorgio; Kizina, Kathrin; Lazaridis, Lazaros; Ahmadipour, Yahya; Rauschenbach, Laurèl; Stuschke, Martin; Pöttgen, Christoph; Guberina, Nika; Tertel, Tobias; Giebel, Bernd; Dreizner, Gian Luca; Barbato, Francesco; Skoda, Eva-Maria; Scheffler, Björn; Müther, Michael; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Deuschl, Cornelius; Glas, Martin; Kebir, Sied
    Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study
    In: Neurological Research and Practice, Jg. 7, 2025, Nr. 1, 51
  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer, Jg. 6, 2025, Nr. 2, S. 307 – 322
  • Oster, Christoph; Reineck, Pia; Schmidt, Teresa; Grieger, Jana; Sharma, Sandeep; Feldheim, Jonas; Kizina, Kathrin; Cappello, Giorgio; Jekel, Leon; Pabst, Kim M.; Ahmadipour, Yahya; Karadachi, Hanah; Rauschenbach, Laurèl; Lazaridis, Lazaros; Guberina, Nika; Pöttgen, Christoph; Blau, Tobias; Keyvani, Kathy; Scheffler, Björn; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Stuschke, Martin; Glas, Martin; Kebir, Sied
    Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort : Time to treat more aggressively?
    In: Neuro-Oncology Advances, Jg. 7, 2025, Nr. 1, vdaf218
  • Zelba, Henning; Shao, Borong; Rabsteyn, Armin; Reinhardt, Annekathrin; Greve, Carsten; Oenning, Lisa; Kayser, Simone; Kyzirakos, Christina; Latzer, Pauline; Riedlinger, Tabea; Bartsch, Oliver; Wünsche, Julian; Harter, Johannes; Feldhahn, Magdalena; Bantel, Yannick; Johänning, Janina; Ködding, Jiri; Hadaschik, Dirk; Schulze, Martin; Battke, Florian; Maksimovic, Olga; Scheble, Veit; Miller, Alexandra M; Castro, Michael; Blumenthal, Deborah T; Glas, Martin; Reardon, David; Biskup, Saskia
    In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination
    In: Journal for ImmunoTherapy of Cancer, Jg. 13, 2025, Nr. 6, e011070
  • Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje; Harting, Inga; Dettmer, Susan; Suwala, Abigail K.; Ketter, Ralf; Tabatabai, Ghazaleh; Seliger, Corinna; Glas, Martin; Burger, Michael C.; Timmer, Marco; Ringel, Florian A.; Mildenberger, Iris; Schulz-Schaeffer, Walter J.; Winkler, Frank; König, Laila; Herold-Mende, Christel; Eisenmenger, Andreas; Pfister, Stefan M.; Renovanz, Mirjam; Bendszus, Martin; Sahm, Felix; Platten, Michael; Kessler, Tobias
    Molecularly matched targeted therapies plus radiotherapy in glioblastoma : the phase 1/2a N²M² umbrella trial
    In: Nature Medicine, Jg. 31, 2025, Nr. 10, S. 3534 – 3541
  • Zeyen, Thomas; Böhm, Laura; Paech, Daniel; Schäfer, Niklas; Tzaridis, Theophilos; Duffy, Cathrina; Nitsch, Louisa; Schneider, Matthias; Potthoff, Anna-Laura; Schneider-Rothhaar, Javen Lennard; Steinbach, Joachim Peter; Hau, Peter; Kowalski, Thomas; Seidel, Clemens; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Zeiner, Pia Susan; Tabatabai, Ghazaleh; Galldiks, Norbert; Stummer, Walter; Hattingen, Elke; Glas, Martin; Gkika, Eleni; Vatter, Hartmut; Radbruch, Alexander; Herrlinger, Ulrich; Weller, Johannes; Schaub, Christina
    Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide
    In: Neuro-Oncology, Jg. 27, 2025, Nr. 2, S. 557 – 566
  • Lazaridis, Lazaros; Moenninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Ahmadipour, Yahya; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Guberina, Nika; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma : A Multicentric Imaging Analysis
    In: Cancer Medicine, Jg. 14, 2025, Nr. 8, e70689
  • Latzer, Pauline; Zelba, Henning; Battke, Florian; Reinhardt, Annekathrin; Shao, Borong; Bartsch, Oliver; Rabsteyn, Armin; Harter, Johannes; Schulze, Martin; Okech, Thomas; Golf, Alexander; Kyzirakos-Feger, Christina; Kayser, Simone; Pieper, Natalia; Feldhahn, Magdalena; Wünsche, Julian; Seitz, Christian; Hadaschik, Dirk; Garbe, Claus; Hauser, Till-Karsten; la Fougère, Christian; Biskup, Dirk; Brooke, Dawn; Parker, David; Martens, Uwe M.; Illerhaus, Gerald; Blumenthal, Deborah T.; Merrell, Ryan; Lorenzo, Luisa Sánchez; Hidvégi, Máté; de Robles, Paula; Kebir, Sied; Li, William W.; Li, Vincent W.; Williams, Matthew; Miller, Alexandra M.; Kesari, Santosh; Castro, Michael; Desjardins, Annick; Ashley, David M.; Friedman, Henry S.; Wen, Patrick Y.; Neil, Elisabeth C.; Iwamoto, Fabio M.; Sipos, Bence; Geletneky, Karsten; Zender, Lars; Glas, Martin; Reardon, David A.; Biskup, Saskia
    A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
    In: Nature Communications, Jg. 15, 2024, Nr. 1, 6870
  • Dobersalske, Celia; Rauschenbach, Laurèl; Hua, Yichao; Berliner, Christoph; Steinbach, Anita; Grüneboom, Anika; Kokkaliaris, Konstantinos D.; Heiland, Dieter H.; Berger, Pia; Langer, Sarah; Tan, Chin L.; Stenzel, Martin; Landolsi, Somaya; Weber, Flora; Darkwah Oppong, Marvin; Werner, Rudolf A.; Gull, Hanah; Schröder, Thomas; Linsenmann, Thomas; Buck, Andreas K.; Gunzer, Matthias; Stuschke, Martin; Keyvani, Kathy; Forsting, Michael; Glas, Martin; Kipnis, Jonathan; Steindler, Dennis A.; Reinhardt, Hans Christian; Green, Edward W.; Platten, Michael; Tasdogan, Alpaslan; Herrmann, Ken; Rambow, Florian; Cima, Igor; Sure, Ulrich; Scheffler, Björn
    Cranioencephalic functional lymphoid units in glioblastoma
    In: Nature Medicine, Jg. 30, 2024, Nr. 10, S. 2947 – 2956
  • Mrugala, Maciej M.; Shi, Wenyin; Iwomoto, Fabio; Lukas, Rimas V.; Palmer, Joshua D.; Suh, John H.; Glas, Martin
    Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022
    In: Journal of Neuro-Oncology, Jg. 169, 2024, Nr. 1, S. 25 – 38
  • Giordano, Frank A.; Layer, Julian P.; Leonardelli, Sonia; Friker, Lea L.; Turiello, Roberta; Corvino, Dillon; Zeyen, Thomas; Schaub, Christina; Müller, Wolf; Sperk, Elena; Schmeel, Leonard Christopher; Sahm, Katharina; Oster, Christoph; Kebir, Sied; Hambsch, Peter; Pietsch, Torsten; Bisdas, Sotirios; Platten, Michael; Glas, Martin; Seidel, Clemens; Herrlinger, Ulrich; Hölzel, Michael
    L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial
    In: Nature Communications, Jg. 15, 2024, Nr. 1, 4210
  • Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M.; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival Data
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1217 – 1223
  • Lacouture, Mario E.; Anadkat, Milan J.; Ballo, Matthew T.; Iwamoto, Fabio; Jeyapalan, Suriya A.; La Rocca, Renato V.; Schwartz, Margaret; Serventi, Jennifer N.; Glas, Martin
    Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
    In: Frontiers in Oncology, Jg. 10, 2020, S. 1045
  • Abstracts

  • Schmidt, T; Oezdemir, Z; Oster, C; Sure, Ulrich; Hermann, K; Stuschke, Martin; Deuschl, Cornelius; Kleinschnitz, Christoph; Müther, M; Glas, Martin; Kebir, Sied
    18-FET-PET Enhanced Diagnosis of Pseudoprogression in Glioblastome is an Independent Prognostic Fator for Overall Survival
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement_5, S. v49 – v50
  • Tabatabai, G.; Freres, P.; Glas, Martin; Hau, P.; von Baumgarten, L.; van den Bent, M.J.; Burger, M.C.; Seidel, C.; Herrlinger, U.; Mildenberger, I.; Neyns, B.; Schafer, H.; Wick, A.; Falk, M.H.; de Freitas Chama, L.L.; Kelemen, P.G.; Schwenke, F.; Koch, S.D.; Roche, P. Romer; Gnad-Vogt, U.S.
    440O First in human study of the mRNA-based cancer vaccine CVGBM in patients (pts) with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma (GBM) : First results from the dose escalation phase
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S406
  • Weller, J; Zeyen, T; Schäfer, N; Hau, P; Glas, Martin; Werner, J; Galldiks, Norbert; Seidel, C; Kowalski, T; Schaub, C; Sabel, M; Drexler, Richard; Schneider, M; Herrlinger, U
    A CCNU/TMZ in Elderly Patients with MGMT-Methylated Glioblastoma : A Multicentric Retrospective Cohort
    19th Meeting of the European Association of Neuro-Oncology (EANO), October 17-20, 2024, Glasgow, UK,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v97 – v97
  • Bähr, O; Tabatabai, Ghazaleh; Fietkau, R; Goldbrunner, R; Glas, Martin
    A Tumor Treating Fields (TTFields) Therapy in Patients with Glioblastoma : Long-Term Survival Results from TTFields in Germany in Routine Clinical Care (Tiger) Study
    19th Meeting of the European Association of Neuro-Oncology (EANO), October 17-20, 2024, Glasgow, UK,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v143
  • Kebir, Sied; Wilms, Sarah; Wenger, Katharina; Kessler, Almuth F; Pröscholdt, Martin; Harapan, Biyan N.; Quach, Stefanie; Hottinger, Andreas F.; Suchorska, Bogdana; Schmidt, Teresa; Oster, Christoph; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Glas, Martin
    AI Based Prediction of Clinical TTFields Response in Glioblastoma Patients (Retrospective Analysis)
    29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii112 – viii112
  • Oster, Christoph; Matyar, Aylin; Hummel, Thomas; Hattingen, Elke; Schmidt, Teresa; Jokisch, Martha; Jokisch, Daniel; Ahmadipour, Yahya; Sure, Ulrich; Stuschke, Martin; Tertel, Tobias; Giebel, Bernd; Kleinschnitz, Christoph; Scheffler, Björn; Deuschl, Cornelius; Kebir, Sied; Glas, Martin
    Decoding glioblastoma survival : Unraveling the prognostic potential of olfactory function in a prospective observational study
    29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii95 – viii95
  • Giordano, F.A.; Layer, J.P.; Friker, L.L.; Turiello, R.; Zeyen, T.; Pregler, B.; Mirallas, O.; Kebir, Sied; Renovanz, M.; Hambsch, P.; Pietsch, T.; Gkika, E.; Platten, M.; Schneider, M.; Grauer, O.; Tabatabai, G.; Glas, Martin; Seidel, C.; Herrlinger, U.; Hölzel, M.
    Dual inhibition of post-radiogenic angio-vasculogenesis in glioblastoma: Results of the phase I/II GLORIA trial
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S408
  • Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje; Harting, Inga; Dettmer, Susan; Suwala, Abigail; Ketter, Ralf; Tabatabai, Ghazaleh; Seliger, Corinna; Glas, Martin; Burger, Michael; Timmer, Marco; Ringel, Florian; Mildenberger, Iris; Schulz-Schaefer, Walter; Renovanz, Mirjam; Bendszus, Martin; Sahm, Felix; Platten, Michael; Kessler, Tobias
    Final Results from N2M2/NOA-20
    29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii117 – viii117
  • Tabatabai, Ghazaleh; Freres, Pierre; Glas, Martin; Hau, Peter; von Baumgarten, Louisa; van Den Bent, Martin; Burger, Michael C; Seidel, Clemens; Herrlinger, Ulrich; Mildenberger, Iris; Neyns, Bart; Schafer, Henning; Wick, Antje; Falk, Martin; de Chama, Laura Leticia Freitas; Kelemen, Peter; Schwenke, Frauke; Koch, Sven D; Roche, Paula Romer; Gnad-Vogt, Ulrike
    First in Human Study of the MRNA-Based Cancer Vaccine CVGBM in Patients (PTS) with Newly-Diagnosed and Surgically Resected MGMT-Unmethylated Glioblastoma (GBM) : First Results from the Dose Escalation Phase
    29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 21-24, 2024, Houston, TX, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 8, S. viii86 – viii86
  • Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje; Harting, Inga; Dettmer, Susan; Suwala, Abigail k; Ketter, Ralf; Tabatabai, Ghazaleh; Seliger-Behme, Corinna; Glas, Martin; Burger, Michael C; Timmer, Marco; Ringel, Florian A; Mildenberger, Iris; Schulz-Schaeffer, Walter J; Renovanz, Mirjam; Bendszus, Martin; Sahm, Felix; Platten, Michael; Kessler, Tobias
    N2M2/NOA-20 : Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 2000
  • Tabatabai, Ghazaleh; Von Baumgarten, Louisa; Van Den Bent, Martin J.; Burger, Michael C.; Freres, Pierre; Glas, Martin; Hau, Peter; Herrlinger, Ulrich; Mildenberger, Iris; Neyns, Bart; Schafer, Henning Sebastian; Seidel, Clemens; Galot, Rachel; Wick, Antje; Falk, Martin H.; de Freitas Chama, Laura Leticia; Kelemen, Peter; Koch, Sven D; Romer Roche, Paula; Gnad-Vogt, Senta Ulrike
    Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, TPS2095
  • Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M; Fendler, Wolfgang P.; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role Of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison Of Tissue, 68ga-Fapi-46 Positron Emission Tomography and Survival Data
    29th Annual Meeting and Education Day of the Society for Neuro-Oncology, November 21-24, 2024, Houston, TX, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 8, S. viii196 – viii197
  • Oster, C; Kessler, Lukas; Blau, T; Keyvani, Kathy; Pabst, K; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, L; Schmidt, T; Feldheim, J; Pierscianek, D; Schildhaus, H; Sure, Ulrich; Ahmadipour, Y; Kleinschnitz, Christoph; Guberina, N; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, 68GA-FAPI-46 Positron Emission Tomography and Survival Data
    19th Meeting of the European Association of Neuro-Oncology (EANO 2024), October 17-20, 2024, Glasgow, UK,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v25 – v25
  • Weller, M; Felsberg, J; Gramatzki, D; Le Rhun, E; Clarke, J; Soffietti, R; Wick, W; Chinot, O; Ducray, F; Roth, P; McDonald, K; Hau, P; Hottinger, A F; Reijneveld, J; Schnell, O; Marosi, C; Glantz, M; Darlix, A; Lombardi, G; Krex, D; Glas, Martin; Reardon, D A; van den Bent, M J; Lefranc, F; Herrlinger, U; Razis, E; Carpentier, A F; Phillips, S; Rudà, R; Wick, A; Tabouret, E; Meyronet, D; Maurage, C; Rushing, E; Rapkins, R
    P11.21.A Long-term survival with IDH wildtype glioblastoma : First results from the eternity brain tumor funders’ collaborative consortium (EORTC1419)
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 2, S. ii77 – ii77
  • Oster, C; Blau, T; Keyvani, Kathy; Schmidt, T; Lazaridis, L; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Herrmann, Ken; Barbato, F; Kebir, Sied; Glas, Martin
    P15.01.A FET PET Sensitivity in primary brain tumors according to CNS who 2021 : Value and pitfalls in presurgical implementation
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 2, S. ii109 – ii109
  • Feldheim, J; Schmidt, T; Oster, Christoph; Feldheim, J; Sure, Ulrich; Kleinschnitz, Christoph; Lazaridis, Lazaros; Kebir, Sied; Glas, Martin
    Telemedicine in Neuro-Oncology : An Evaluation of Remote Consultations during the COVID-19 Pandemic
    18th Meeting of the European Association of Neuro-Oncology, September 21-24, 2023, Rotterdam, The Netherlands,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Supplement 2, S. ii16 – ii17
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120
  • Poster / Posterbeiträge

  • Weiten, Richard; Rieger, Constantin; von Brandenstein, Melanie; Storz, Enno; Tolkach, Yuri; Stehle, Thomas; Schmidt, Teresa; Glas, Martin; Blau, Tobias; Keyvani, Kathy; Grünwald, Viktor; Hölzel, Michael; Heidenreich, Axel; Eckstein, Markus; Klümper, Niklas
    Frequent overexpression of NECTIN-4 in CNS metastases from urothelial carcinoma
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 804
  • Bähr, Oliver; Tabatabai, Ghazaleh; Fietkau, Rainer; Goldbrunner, Roland; Glas, Martin
    Tumor treating fields (TTFields) therapy in patients with glioblastoma : Long-term survival results from TTFields in Germany in routine clinical care (TIGER) study
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 16, 2036